The University of Illinois Urbana-Champaign (UIUC) and Infosys, a provider of next-generation digital services and consulting has formed a strategic partnership to develop precision medicine solutions. As part of the strategic partnership, Infosys becomes a member of the Center for Computational Biotechnology and Genomic Medicine (CCBGM).
Precision Medicine Strategic Partnership Details
The adoption of precision medicine solutions by healthcare companies has significant benefits, including allowing caregivers to predict patients’ diseases and control prohibitive healthcare costs, in turn benefiting both patients and healthcare companies. This partnership will combine Infosys’ strength in advanced machine learning, its artificial intelligence capabilities through the Infosys Nia platform, with UIUC’s expertise in computing systems, bioinformatics, and genomic applications, to improve preventive care and enhance predictability of treatment outcomes of potential diseases.
Why It Matters
“The future of precision medicine, which allows tailoring diagnosis and treatment to each patient in order to optimize outcome, is dependent on the ability to jointly analyze large datasets of heterogeneous biological (genomic, metabolic, neuroimaging, etc.) and clinical measures while incorporating key clinical domain knowledge. This is a complex challenge and will require innovations in both data-driven analytics and system design to succeed.” said Professor Ravishankar K Iyer, Electrical and Computer Engineering, University of Illinois and CoPI of the CCBGM.